Amplio Pharma Investors

Amplio Pharma B.V. is privately owned, Dutch company.

​

Amplio Pharma has raised capital through a Pre-seed (CL) and Seed Round (equity).

The funds are invested in the clinical development of NovoBioJect (Phase 1b in RA)